First Off The Blocks, Fresenius Launches US Tocilizumab Biosimilar
Tyenne Version Is Approved In SC And IV Formulations; Rival Biogen Is Yet To Launch
• By David Wallace
Fresenius Kabi has been first to launch a US tocilizumab biosimilar • Source: Shutterstock 
